Your browser is no longer supported. Please, upgrade your browser.
BRK-B Berkshire Hathaway Inc. weekly Stock Chart
BRK-B [NYSE]
Berkshire Hathaway Inc.
IndexS&P 500 P/E0.03 EPS (ttm)6142.19 Insider Own0.18% Shs Outstand2.43B Perf Week7.00%
Market Cap509.04B Forward P/E19.22 EPS next Y10.90 Insider Trans0.00% Shs Float1.19B Perf Month17.16%
Income- PEG0.00 EPS next Q2.24 Inst Own68.84% Short Float1.07% Perf Quarter18.46%
Sales256.69B P/S1.98 EPS this Y-2.90% Inst Trans- Short Ratio1.91 Perf Half Y-7.87%
Book/sh229292.47 P/B0.00 EPS next Y14.70% ROA- Target Price217.50 Perf Year4.47%
Cash/sh- P/C- EPS next 5Y23.30% ROE- 52W Range159.50 - 231.61 Perf YTD-7.51%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-9.55% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low31.34% ATR3.49
Employees391500 Current Ratio- Sales Q/Q1.00% Oper. Margin- RSI (14)76.82 Volatility1.90% 1.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.92 Prev Close205.02
ShortableYes LT Debt/Eq- EarningsAug 07 AMC Payout- Avg Volume6.66M Price209.48
Recom2.20 SMA208.19% SMA5011.67% SMA2003.64% Volume6,148,935 Change2.18%
Sep-14-17Initiated JP Morgan Overweight $210
Aug-11-17Reiterated Barclays Overweight $191 → $205
Jan-07-16Reiterated Barclays Overweight $169 → $166
Aug-10-15Reiterated Barclays Overweight $173 → $169
Jul-01-13Reiterated Barclays Overweight $126 → $131
May-06-13Reiterated Barclays Overweight $119 → $126
Jan-03-13Reiterated Barclays Overweight $103 → $105
Aug-06-12Reiterated Barclays Overweight $95 → $100
Aug-09-11Upgrade Barclays Capital Equal Weight → Overweight $85 → $85
Apr-12-10Initiated Barclays Capital Equal Weight
Aug-07-20 08:22PM  
06:26PM  
05:30PM  
11:39AM  
05:00AM  
Aug-06-20 04:25PM  
04:15PM  
04:14PM  
03:03PM  
01:22PM  
12:38PM  
11:05AM  
11:03AM  
Aug-05-20 05:44PM  
04:25PM  
12:31PM  
11:29AM  
11:23AM  
11:09AM  
10:33AM  
07:00AM  
Aug-04-20 05:37PM  
05:19PM  
04:25PM  
10:37AM  
08:00AM  
07:21AM  
Aug-03-20 06:43PM  
06:05PM  
05:45PM  
04:25PM  
11:20AM  
08:43AM  
06:06AM  
06:00AM  
Aug-02-20 07:21AM  
Aug-01-20 08:13AM  
Jul-31-20 06:59PM  
05:37PM  
04:42PM  
04:25PM  
03:17PM  
11:03AM  
11:02AM  
10:57AM  
10:54AM  
10:27AM  
10:27AM  
10:18AM  
10:15AM  
07:00AM  
06:54AM  
05:51AM  
Jul-30-20 11:10PM  
10:47PM  
07:18PM  
04:25PM  
03:57PM  
03:31PM  
01:43PM  
01:12PM  
12:11PM  
08:50AM  
06:48AM  
06:06AM  
05:00AM  
Jul-29-20 06:56PM  
03:13PM  
11:03AM  
10:56AM  
Jul-28-20 06:58PM  
06:45PM  
02:12PM  
02:11PM  
10:10AM  
06:41AM  
06:06AM  
Jul-27-20 05:45PM  
01:09PM  
12:26PM  
06:41AM  
01:00AM  
Jul-26-20 12:34PM  
09:00AM  
07:00AM  
Jul-25-20 11:51AM  
11:40AM  
Jul-24-20 07:42PM  
06:43PM  
12:13PM  
10:57AM  
10:30AM  
10:25AM  
07:00AM  
Jul-23-20 04:23PM  
02:58PM  
12:52PM  
10:35AM  
09:41AM  
09:14AM  
Berkshire Hathaway Inc., through its subsidiaries, engages in insurance, freight rail transportation, and utility businesses. It provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. The company also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydro, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, and compressor and meter stations; and holds interest in coal mining assets. In addition, it offers real estate brokerage services; and leases transportation equipment and furniture. Further, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; flooring, insulation, roofing and engineered, building and engineered components, paints and coatings, and bricks and masonry products, as well as offers homebuilding and manufactured housing finance; and recreational vehicles, apparel products, jewelry, and custom picture framing products, and alkaline batteries. Additionally, it manufactures castings, forgings, fasteners/fastener systems, and aerostructures; and seamless pipes, fittings, downhole casing and tubing, and various mill forms. The company distributes newspapers, televisions, and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and fractional aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle accessories. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.
V Visa Inc. weekly Stock Chart
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E35.34 EPS (ttm)5.56 Insider Own0.20% Shs Outstand2.13B Perf Week3.13%
Market Cap426.09B Forward P/E33.64 EPS next Y5.84 Insider Trans-4.24% Shs Float1.67B Perf Month2.16%
Income12.03B PEG3.49 EPS next Q1.09 Inst Own97.10% Short Float2.20% Perf Quarter6.09%
Sales23.89B P/S17.84 EPS this Y20.00% Inst Trans-0.02% Short Ratio4.30 Perf Half Y-3.15%
Book/sh14.17 P/B13.86 EPS next Y16.51% ROA15.20% Target Price219.22 Perf Year9.15%
Cash/sh7.67 P/C25.61 EPS next 5Y10.12% ROE38.30% 52W Range133.93 - 214.17 Perf YTD4.50%
Dividend1.20 P/FCF47.32 EPS past 5Y19.80% ROI26.50% 52W High-8.32% Beta0.90
Dividend %0.61% Quick Ratio1.60 Sales past 5Y12.60% Gross Margin81.60% 52W Low46.61% ATR4.23
Employees19500 Current Ratio1.60 Sales Q/Q-17.20% Oper. Margin61.40% RSI (14)50.81 Volatility1.85% 2.12%
OptionableYes Debt/Eq0.69 EPS Q/Q-21.70% Profit Margin47.40% Rel Volume0.66 Prev Close198.77
ShortableYes LT Debt/Eq0.59 EarningsJul 28 AMC Payout21.80% Avg Volume8.52M Price196.36
Recom1.80 SMA200.67% SMA500.83% SMA2005.69% Volume5,603,058 Change-1.21%
Jul-21-20Resumed Daiwa Securities Neutral $204
Jul-14-20Initiated Goldman Buy $223
Jun-23-20Resumed Oppenheimer Outperform $190 → $202
Jun-17-20Reiterated Citigroup Buy $205 → $223
Jun-02-20Reiterated SunTrust Buy $200 → $220
Jun-01-20Resumed Oppenheimer Outperform
Apr-22-20Downgrade Guggenheim Buy → Neutral
Apr-15-20Downgrade Jefferies Buy → Hold $190 → $180
Jan-21-20Initiated Macquarie Outperform $250
Jan-16-20Reiterated Oppenheimer Outperform $202 → $210
Dec-05-19Initiated Compass Point Buy
Oct-25-19Reiterated BMO Capital Markets Outperform $231 → $239
Jul-19-19Reiterated Barclays Overweight $181 → $195
May-02-19Resumed Goldman Buy $188
Jan-29-19Initiated Jefferies Buy
Jul-24-18Resumed Raymond James Outperform
May-18-18Initiated UBS Neutral
Mar-28-18Initiated Bernstein Outperform
Jan-29-18Reiterated Citigroup Buy $136 → $145
Jan-12-18Reiterated Citigroup Buy $124 → $136
Aug-07-20 01:29PM  
12:08PM  
12:07PM  
09:43AM  
Aug-06-20 11:56AM  
Aug-05-20 04:19PM  
11:01AM  
Aug-04-20 02:59PM  
09:33AM  
03:01AM  
Aug-03-20 05:34PM  
01:36PM  
12:08PM  
09:45AM  
07:51AM  
07:08AM  
Jul-31-20 05:03PM  
11:09AM  
10:32AM  
10:08AM  
08:32AM  
Jul-30-20 03:08PM  
10:42AM  
07:03AM  
Jul-29-20 05:14PM  
01:50PM  
01:17PM  
12:29PM  
11:28AM  
10:41AM  
09:57AM  
03:03AM  
12:54AM  
Jul-28-20 10:34PM  
08:39PM  
07:20PM  
05:43PM  
05:25PM  
05:12PM  
04:52PM  
04:28PM  
04:24PM  
04:09PM  
Jul-27-20 11:48PM  
12:10PM  
07:01AM  
Jul-24-20 01:46PM  
01:37PM  
08:08AM  
07:00AM  
Jul-22-20 04:11PM  
06:06AM  
Jul-21-20 12:31PM  
08:00AM  
Jul-20-20 05:45PM  
03:23PM  
08:00AM  
01:30AM  
Jul-18-20 10:19AM  
Jul-17-20 11:33AM  
05:51AM  
Jul-16-20 03:59PM  
02:59PM  
01:58PM  
11:46AM  
06:07AM  
06:00AM  
Jul-15-20 05:43PM  
03:51PM  
Jul-13-20 02:25PM  
11:11AM  
Jul-10-20 03:50PM  
05:28AM  
Jul-08-20 01:08PM  
07:02AM  
06:15AM  
06:00AM  
Jul-07-20 05:45PM  
04:05PM  
08:44AM  
Jul-06-20 02:00PM  
08:30AM  
Jul-05-20 07:05PM  
04:30PM  
Jul-02-20 05:50PM  
11:56AM  
08:17AM  
Jul-01-20 11:15AM  
08:30AM  
06:24AM  
Jun-30-20 05:56PM  
05:33PM  
12:00AM  
Jun-29-20 05:45PM  
01:50PM  
12:49PM  
12:10PM  
Jun-28-20 07:00AM  
Jun-27-20 01:06PM  
Jun-26-20 02:53AM  
Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions. In addition, the company offers card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. Visa Inc. has a strategic partnership with NovoPayment to enable financial institutions and merchants to deploy Visa's digital solutions in Latin America and the Caribbean; and a strategic agreement with Intuit Inc. The company was founded in 1958 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARNEY LLOYDDirectorAug 04Sale192.641,550298,5922,962Aug 05 04:34 PM
KELLY ALFRED F JRCHAIRMAN & CEOJul 30Option Exercise80.824,000323,280130,090Jul 31 04:33 PM
KELLY ALFRED F JRCHAIRMAN & CEOJul 30Sale195.007,0001,365,000123,090Jul 31 04:33 PM
KELLY ALFRED F JRCHAIRMAN & CEOJun 30Option Exercise80.824,000323,280133,090Jul 01 05:09 PM
KELLY ALFRED F JRCHAIRMAN & CEOJun 30Sale191.497,0001,340,430126,090Jul 01 05:09 PM
Taneja RajatPRESIDENT, TECHNOLOGYJun 10Option Exercise53.643,279175,869221,282Jun 12 05:59 PM
Taneja RajatPRESIDENT, TECHNOLOGYJun 10Sale202.023,279662,413218,003Jun 12 05:59 PM
PRABHU VASANT MVICE CHAIR & CFOJun 02Sale197.0836,6247,217,96043,143Jun 04 04:49 PM
KELLY ALFRED F JRCHAIRMAN & CEOMay 29Option Exercise80.824,000323,280136,090Jun 02 05:37 PM
KELLY ALFRED F JRCHAIRMAN & CEOMay 29Sale194.507,0001,361,500129,090Jun 02 05:37 PM
MCINERNEY RYANPRESIDENTMay 27Sale191.8726,1505,017,380107,626May 28 04:51 PM
KELLY ALFRED F JRCHAIRMAN & CEOApr 30Option Exercise80.824,000323,280139,090May 04 07:35 PM
KELLY ALFRED F JRCHAIRMAN & CEOApr 30Sale181.787,0001,272,460132,090May 04 07:35 PM
KELLY ALFRED F JRCHAIRMAN & CEOMar 30Option Exercise80.824,000323,280142,090Mar 31 07:03 PM
KELLY ALFRED F JRCHAIRMAN & CEOMar 30Sale161.407,0001,129,800135,090Mar 31 07:03 PM
KELLY ALFRED F JRCHAIRMAN & CEOFeb 28Option Exercise80.824,000323,280145,090Feb 28 08:33 PM
KELLY ALFRED F JRCHAIRMAN & CEOFeb 28Sale174.047,0001,218,280138,090Feb 28 08:33 PM
Biggar LynneEVP, CHIEF MRKTNG & COMM OFFFeb 18Option Exercise109.825,500604,01019,370Feb 20 05:32 PM
Biggar LynneEVP, CHIEF MRKTNG & COMM OFFFeb 18Sale211.185,5001,161,51113,870Feb 20 05:32 PM
Taneja RajatPRESIDENT, TECHNOLOGYFeb 14Option Exercise53.6410,685573,090228,688Feb 18 05:29 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 14Sale208.712,186456,2460Feb 18 05:33 PM
Taneja RajatPRESIDENT, TECHNOLOGYFeb 14Sale208.2910,6852,225,579218,003Feb 18 05:29 PM
Taneja RajatPRESIDENT, TECHNOLOGYFeb 13Option Exercise53.6464,3153,449,535282,318Feb 18 05:29 PM
Taneja RajatPRESIDENT, TECHNOLOGYFeb 13Sale207.8464,31513,366,959218,003Feb 18 05:29 PM
KELLY ALFRED F JRCHAIRMAN & CEOJan 30Option Exercise80.824,000323,280148,090Feb 03 05:04 PM
KELLY ALFRED F JRCHAIRMAN & CEOJan 30Sale204.007,0001,428,000141,090Feb 03 05:04 PM
KELLY ALFRED F JRCHAIRMAN & CEODec 30Option Exercise80.824,000323,280150,514Dec 30 07:10 PM
KELLY ALFRED F JRCHAIRMAN & CEODec 30Sale189.317,0001,325,170143,514Dec 30 07:10 PM
Sheedy William M.EVP, THE STRATEGY GROUPDec 02Sale181.7813,2062,400,556240,854Dec 03 04:35 PM
KELLY ALFRED F JRCHAIRMAN & CEONov 29Option Exercise80.824,000323,28084,788Dec 03 04:39 PM
KELLY ALFRED F JRCHAIRMAN & CEONov 29Sale183.727,0001,286,04077,788Dec 03 04:39 PM
Sheedy William M.EVP, THE STRATEGY GROUPNov 20Sale182.523,110567,622228,694Nov 21 04:25 PM
KELLY ALFRED F JRCHAIRMAN & CEOOct 30Option Exercise80.824,000323,28055,446Nov 01 04:30 PM
KELLY ALFRED F JRCHAIRMAN & CEOOct 30Sale177.797,0001,244,53048,446Nov 01 04:30 PM
Sheedy William M.EVP, THE STRATEGY GROUPOct 29Sale178.7121,1643,782,284227,126Oct 30 05:02 PM
PRABHU VASANT MVICE CHAIR & CFOAug 21Sale181.1425,0514,537,64037,172Aug 23 04:29 PM
AMGN Amgen Inc. weekly Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E19.66 EPS (ttm)12.24 Insider Own0.20% Shs Outstand588.00M Perf Week-1.63%
Market Cap141.82B Forward P/E14.27 EPS next Y16.86 Insider Trans-0.41% Shs Float580.14M Perf Month-4.36%
Income7.30B PEG2.67 EPS next Q3.80 Inst Own78.60% Short Float0.95% Perf Quarter2.50%
Sales24.30B P/S5.84 EPS this Y2.00% Inst Trans0.30% Short Ratio2.09 Perf Half Y4.95%
Book/sh18.13 P/B13.28 EPS next Y7.04% ROA11.90% Target Price262.76 Perf Year29.94%
Cash/sh19.38 P/C12.42 EPS next 5Y7.36% ROE71.70% 52W Range177.05 - 264.97 Perf YTD-0.16%
Dividend6.40 P/FCF21.51 EPS past 5Y14.00% ROI21.20% 52W High-9.16% Beta0.93
Dividend %2.66% Quick Ratio1.80 Sales past 5Y3.10% Gross Margin78.20% 52W Low35.94% ATR6.29
Employees23400 Current Ratio2.20 Sales Q/Q5.70% Oper. Margin37.90% RSI (14)42.75 Volatility1.83% 2.23%
OptionableYes Debt/Eq3.21 EPS Q/Q-14.70% Profit Margin30.00% Rel Volume0.51 Prev Close241.55
ShortableYes LT Debt/Eq3.20 EarningsJul 28 AMC Payout49.50% Avg Volume2.63M Price240.69
Recom2.20 SMA20-4.06% SMA500.21% SMA2005.59% Volume1,346,540 Change-0.36%
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Aug-06-20 04:10PM  
Aug-04-20 08:29AM  
Aug-03-20 07:56AM  
07:30AM  
07:00AM  
05:45AM  
Jul-30-20 10:24AM  
07:59AM  
06:27AM  
06:19AM  
Jul-29-20 12:25PM  
11:03AM  
10:14AM  
Jul-28-20 09:30PM  
08:49PM  
05:25PM  
05:18PM  
04:51PM  
04:25PM  
04:03PM  
08:19AM  
Jul-27-20 12:05PM  
Jul-26-20 12:34PM  
Jul-24-20 08:07PM  
11:13AM  
Jul-23-20 05:05PM  
05:00PM  
04:15PM  
04:00PM  
03:55PM  
Jul-21-20 12:31PM  
09:00AM  
09:00AM  
07:01AM  
Jul-16-20 06:22PM  
10:31AM  
09:27AM  
Jul-15-20 03:35PM  
03:29PM  
Jul-13-20 10:51AM  
10:11AM  
06:40AM  
Jul-12-20 10:00PM  
Jul-09-20 07:34AM  
Jul-08-20 10:22AM  
Jul-07-20 05:02PM  
03:42PM  
02:41PM  
10:00AM  
08:17AM  
Jul-06-20 10:11AM  
07:00AM  
Jul-02-20 01:35PM  
11:00AM  
09:03AM  
08:55AM  
Jul-01-20 07:28PM  
04:25PM  
03:47PM  
03:30PM  
02:51PM  
02:35PM  
01:35PM  
01:28PM  
12:28PM  
11:50AM  
10:42AM  
Jun-29-20 06:57PM  
Jun-26-20 09:41AM  
Jun-24-20 02:00PM  
11:00AM  
11:00AM  
Jun-23-20 12:09PM  
Jun-22-20 05:17PM  
04:00PM  
11:30AM  
Jun-19-20 12:00PM  
Jun-18-20 04:00PM  
Jun-16-20 01:05PM  
Jun-15-20 09:36AM  
09:24AM  
Jun-14-20 11:16AM  
Jun-12-20 07:06PM  
11:16AM  
Jun-11-20 11:30AM  
Jun-08-20 02:48PM  
07:55AM  
Jun-05-20 04:00PM  
Jun-04-20 08:14AM  
Jun-03-20 11:38AM  
Jun-02-20 06:00AM  
Jun-01-20 09:53AM  
08:00AM  
07:47AM  
May-30-20 11:31AM  
May-29-20 07:38PM  
04:32PM  
12:39PM  
08:00AM  
May-28-20 05:25PM  
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorJul 22Option Exercise54.691,00054,69016,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJul 22Sale259.791,000259,79015,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJun 17Option Exercise54.691,00054,69016,576Jun 17 06:11 PM
SUGAR RONALD DDirectorJun 17Sale228.541,000228,54015,576Jun 17 06:11 PM
SUGAR RONALD DDirectorMay 20Option Exercise54.691,00054,69016,482May 20 09:24 PM
SUGAR RONALD DDirectorMay 20Sale229.271,000229,27015,482May 20 09:24 PM
Williams R SandersDirectorMay 06Sale237.31425100,8575,409May 07 08:49 PM
SUGAR RONALD DDirectorApr 22Option Exercise54.691,00054,69015,636Apr 22 07:07 PM
SUGAR RONALD DDirectorApr 22Sale233.351,000233,35014,636Apr 22 07:07 PM
Bradway Robert AChairman, CEO and PresidentApr 13Option Exercise58.43127,0007,420,610595,516Apr 13 07:54 PM
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
MMM 3M Company weekly Stock Chart
MMM [NYSE]
3M Company
IndexDJIA S&P500 P/E17.95 EPS (ttm)8.82 Insider Own0.10% Shs Outstand577.00M Perf Week5.22%
Market Cap92.20B Forward P/E17.52 EPS next Y9.04 Insider Trans-9.30% Shs Float574.88M Perf Month4.54%
Income5.13B PEG8.21 EPS next Q2.12 Inst Own68.00% Short Float1.13% Perf Quarter6.61%
Sales31.35B P/S2.94 EPS this Y-14.90% Inst Trans0.30% Short Ratio1.96 Perf Half Y-1.09%
Book/sh18.82 P/B8.41 EPS next Y10.39% ROA11.50% Target Price162.87 Perf Year-3.59%
Cash/sh7.67 P/C20.65 EPS next 5Y2.19% ROE49.20% 52W Range114.04 - 182.54 Perf YTD-10.25%
Dividend5.88 P/FCF36.43 EPS past 5Y0.90% ROI16.30% 52W High-13.27% Beta0.97
Dividend %3.71% Quick Ratio1.40 Sales past 5Y0.20% Gross Margin47.90% 52W Low38.84% ATR3.25
Employees96163 Current Ratio1.90 Sales Q/Q-12.20% Oper. Margin21.40% RSI (14)52.64 Volatility1.59% 1.80%
OptionableYes Debt/Eq1.91 EPS Q/Q15.50% Profit Margin16.40% Rel Volume0.65 Prev Close156.00
ShortableYes LT Debt/Eq1.78 EarningsJul 28 BMO Payout65.40% Avg Volume3.32M Price158.33
Recom3.20 SMA201.23% SMA500.70% SMA2000.02% Volume2,165,253 Change1.49%
Mar-30-20Downgrade Gordon Haskett Hold → Underperform
Jan-09-20Upgrade Wolfe Research Underperform → Peer Perform
Dec-23-19Upgrade JP Morgan Underweight → Neutral $143 → $150
Dec-12-19Downgrade UBS Neutral → Sell $180 → $160
Dec-09-19Downgrade Citigroup Buy → Neutral $180
Oct-03-19Reiterated Barclays Underweight $162 → $158
Jul-12-19Reiterated UBS Neutral $201 → $182
Jul-09-19Downgrade RBC Capital Mkts Outperform → Sector Perform $207 → $176
Apr-29-19Downgrade Gordon Haskett Buy → Hold
Apr-26-19Initiated Argus Hold
Apr-26-19Downgrade BofA/Merrill Buy → Neutral
Oct-12-18Initiated Gordon Haskett Buy
Oct-12-18Initiated Credit Suisse Outperform
Aug-21-18Initiated Morgan Stanley Equal-Weight $212
May-16-18Downgrade Jefferies Buy → Hold
May-03-18Upgrade RBC Capital Mkts Sector Perform → Outperform $238
Apr-03-18Reiterated Stifel Hold $251 → $225
Feb-15-18Initiated Barclays Underweight $235
Feb-13-18Upgrade Deutsche Bank Hold → Buy $240 → $275
Jan-24-18Upgrade Hilliard Lyons Neutral → Buy
Aug-07-20 04:25PM  
Aug-06-20 04:25PM  
Aug-05-20 04:26PM  
01:15PM  
01:15PM  
09:45AM  
07:39AM  
Aug-04-20 04:25PM  
08:15AM  
Aug-03-20 04:25PM  
03:15PM  
06:09AM  
Jul-31-20 05:21PM  
04:25PM  
02:14PM  
12:30PM  
Jul-30-20 04:25PM  
Jul-29-20 11:45AM  
10:38AM  
10:08AM  
06:43AM  
01:01AM  
Jul-28-20 07:20PM  
04:47PM  
04:11PM  
03:43PM  
02:47PM  
02:39PM  
02:27PM  
01:18PM  
01:16PM  
01:00PM  
12:05PM  
11:50AM  
11:40AM  
11:28AM  
11:25AM  
10:33AM  
10:22AM  
10:12AM  
09:45AM  
09:10AM  
08:54AM  
07:34AM  
06:41AM  
06:30AM  
05:30AM  
03:31AM  
Jul-27-20 02:14PM  
Jul-24-20 12:00PM  
10:05AM  
Jul-22-20 11:30AM  
Jul-20-20 05:20PM  
01:17PM  
01:12PM  
11:55AM  
09:45AM  
Jul-16-20 05:03PM  
08:47AM  
08:37AM  
Jul-14-20 11:45PM  
02:14PM  
01:33PM  
11:00AM  
07:31AM  
07:20AM  
07:00AM  
07:00AM  
06:01AM  
Jul-12-20 09:10AM  
Jul-10-20 01:39PM  
Jul-09-20 09:45AM  
Jul-07-20 11:29AM  
Jul-06-20 01:11PM  
10:52AM  
Jul-01-20 11:11AM  
Jun-30-20 03:41PM  
Jun-29-20 11:55AM  
Jun-23-20 02:07PM  
09:35AM  
Jun-17-20 06:00AM  
Jun-16-20 08:34AM  
Jun-15-20 03:18PM  
03:17PM  
03:00PM  
10:10AM  
09:51AM  
09:45AM  
09:21AM  
06:43AM  
06:30AM  
Jun-11-20 07:15AM  
Jun-09-20 10:30AM  
08:20AM  
01:28AM  
Jun-08-20 06:00PM  
02:56PM  
Jun-05-20 11:34AM  
Jun-03-20 03:55PM  
09:43AM  
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shafer Stephen MSenior Vice PresidentJun 01Option Exercise155.581,298201,9433,438Jun 03 01:27 PM
Vale Michael G.Executive Vice PresidentMay 08Option Exercise89.477,812698,94054,712May 11 10:54 AM
Vale Michael G.Executive Vice PresidentMay 08Sale148.3414,0622,085,98846,900May 11 10:54 AM
Hammes Eric D.Executive Vice PresidentMay 06Option Exercise89.471,02691,79610,827May 07 10:52 AM
Hammes Eric D.Executive Vice PresidentMay 06Sale146.361,026150,1659,801May 07 10:52 AM
Keel Paul AExecutive Vice PresidentMay 05Option Exercise89.478,249738,03825,080May 06 10:04 AM
Keel Paul AExecutive Vice PresidentMay 05Sale147.1710,2491,508,29716,831May 06 10:04 AM
Ashish Khandpur KExecutive Vice PresidentMay 04Option Exercise89.473,605322,53919,193May 05 11:29 AM
Silberhorn Ty RSenior Vice PresidentMay 04Option Exercise101.4914,6231,484,08816,571May 05 11:35 AM
Ashish Khandpur KExecutive Vice PresidentMay 04Sale146.853,605529,39915,588May 05 11:29 AM
Silberhorn Ty RSenior Vice PresidentMay 04Sale146.4614,6232,141,6851,948May 05 11:35 AM
Roman Michael FChairman, President & CEOMay 01Option Exercise89.4710,067900,69457,868May 04 04:36 PM
Roman Michael FChairman, President & CEOMay 01Sale148.707,8941,173,82749,974May 04 04:36 PM
Silberhorn Ty RSenior Vice PresidentFeb 21Option Exercise101.491,967199,6313,849Feb 24 10:33 AM
Silberhorn Ty RSenior Vice PresidentFeb 21Sale158.191,967311,1601,882Feb 24 10:33 AM
Vale Michael G.Executive Vice PresidentFeb 18Sale159.176,250994,80352,604Feb 19 01:11 PM
Reinseth Theresa EVice President/CAOFeb 07Option Exercise160.0839463,0721,315Feb 10 10:06 AM
Roman Michael FChairman, President & CEOJan 31Option Exercise78.728,906701,08048,152Feb 03 02:52 PM
Roman Michael FChairman, President & CEOJan 31Sale162.008,9061,442,77239,246Feb 03 02:52 PM
Bushman Julie LExecutive Vice PresidentDec 02Sale170.166,8791,170,53133,652Dec 03 02:50 PM
Bushman Julie LExecutive Vice PresidentNov 29Option Exercise169.7712,6462,146,91146,298Dec 03 02:50 PM
Roman Michael FChairman, President & CEONov 29Option Exercise169.7712,6462,146,91145,288Dec 02 05:56 PM
Vale Michael G.Executive Vice PresidentNov 29Option Exercise169.7712,6462,146,91156,456Dec 02 04:44 PM
Silberhorn Ty RSenior Vice PresidentNov 13Option Exercise87.891,634143,6121,967Nov 14 12:25 PM
Silberhorn Ty RSenior Vice PresidentNov 13Sale170.721,634278,950333Nov 14 12:25 PM
Ashish Khandpur KExecutive Vice PresidentNov 05Option Exercise78.723,362264,65713,988Nov 06 11:06 AM
Hammes Eric D.Senior Vice PresidentNov 05Option Exercise78.721,341105,5648,520Nov 06 10:49 AM
Hammes Eric D.Senior Vice PresidentNov 05Sale174.251,341233,6697,179Nov 06 10:49 AM
Ashish Khandpur KExecutive Vice PresidentNov 05Sale174.203,362585,65110,626Nov 06 11:06 AM
MA Mastercard Incorporated weekly Stock Chart
MA [NYSE]
Mastercard Incorporated
IndexS&P 500 P/E42.11 EPS (ttm)7.79 Insider Own11.10% Shs Outstand1.00B Perf Week6.32%
Market Cap329.75B Forward P/E37.66 EPS next Y8.71 Insider Trans-1.63% Shs Float876.71M Perf Month11.35%
Income7.92B PEG3.33 EPS next Q1.65 Inst Own77.60% Short Float0.50% Perf Quarter16.14%
Sales17.00B P/S19.39 EPS this Y43.30% Inst Trans-0.09% Short Ratio1.06 Perf Half Y0.31%
Book/sh6.44 P/B50.93 EPS next Y30.91% ROA24.80% Target Price336.88 Perf Year17.98%
Cash/sh11.47 P/C28.61 EPS next 5Y12.66% ROE128.90% 52W Range199.99 - 347.25 Perf YTD9.86%
Dividend1.60 P/FCF48.99 EPS past 5Y20.70% ROI55.60% 52W High-5.54% Beta1.06
Dividend %0.49% Quick Ratio2.00 Sales past 5Y12.30% Gross Margin- 52W Low64.02% ATR7.09
Employees18600 Current Ratio2.00 Sales Q/Q-18.90% Oper. Margin52.80% RSI (14)64.37 Volatility2.04% 2.25%
OptionableYes Debt/Eq0.00 EPS Q/Q-29.50% Profit Margin43.10% Rel Volume0.89 Prev Close330.14
ShortableYes LT Debt/Eq1.93 EarningsJul 30 BMO Payout20.10% Avg Volume4.11M Price328.02
Recom1.90 SMA206.31% SMA507.79% SMA20012.88% Volume3,648,497 Change-0.64%
Jul-21-20Resumed Daiwa Securities Neutral $314
Jul-14-20Initiated Goldman Buy $364
Jun-23-20Downgrade Oppenheimer Outperform → Perform
Jun-01-20Resumed Oppenheimer Outperform
Apr-16-20Downgrade Guggenheim Buy → Neutral
Apr-15-20Downgrade Jefferies Buy → Hold $290 → $275
Jan-21-20Initiated Macquarie Outperform $365
Jan-16-20Reiterated Oppenheimer Outperform $312 → $345
Dec-05-19Initiated Compass Point Buy
Jul-19-19Reiterated Barclays Overweight $285 → $310
Jan-29-19Initiated Jefferies Buy
Jan-09-19Upgrade UBS Neutral → Buy
Jan-08-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Upgrade Edward Jones Hold → Buy
Jul-24-18Resumed Raymond James Outperform
May-18-18Initiated UBS Neutral
Mar-28-18Initiated Bernstein Outperform
Feb-02-18Upgrade Argus Hold → Buy $200
Feb-01-18Upgrade Sandler O'Neill Sell → Hold
Jan-04-18Downgrade RBC Capital Mkts Top Pick → Outperform
Aug-07-20 10:02AM  
09:43AM  
Aug-06-20 03:45PM  
01:33PM  
11:56AM  
Aug-05-20 06:34PM  
04:19PM  
Aug-04-20 04:35PM  
Aug-03-20 08:58AM  
07:51AM  
Jul-31-20 05:21PM  
05:03PM  
01:04PM  
Jul-30-20 09:01PM  
02:06PM  
01:08PM  
12:34PM  
10:44AM  
10:34AM  
10:27AM  
10:06AM  
09:33AM  
09:15AM  
08:57AM  
08:08AM  
08:04AM  
Jul-29-20 02:56PM  
01:24PM  
10:56AM  
10:09AM  
Jul-28-20 04:30PM  
01:43PM  
10:00AM  
07:31AM  
Jul-27-20 01:04PM  
12:38PM  
12:10PM  
Jul-25-20 10:33AM  
Jul-24-20 01:46PM  
10:25AM  
07:00AM  
Jul-23-20 12:33PM  
12:20PM  
10:36AM  
Jul-21-20 08:45PM  
05:45PM  
12:26PM  
11:10AM  
08:44AM  
08:00AM  
Jul-20-20 07:26PM  
02:48PM  
05:00AM  
Jul-19-20 07:21AM  
Jul-17-20 02:58PM  
11:02AM  
09:55AM  
Jul-16-20 06:03PM  
02:47PM  
06:07AM  
06:03AM  
06:00AM  
Jul-15-20 05:22PM  
01:30PM  
12:30PM  
11:32AM  
08:31AM  
08:10AM  
Jul-14-20 04:05PM  
03:18PM  
02:04PM  
Jul-13-20 05:45PM  
02:25PM  
Jul-11-20 08:00AM  
Jul-10-20 11:11AM  
Jul-09-20 01:10PM  
12:56PM  
11:30AM  
Jul-08-20 10:00PM  
09:01AM  
06:00AM  
Jul-07-20 05:50PM  
12:10PM  
08:44AM  
Jul-06-20 08:30AM  
Jul-02-20 05:48PM  
01:39PM  
11:56AM  
10:29AM  
08:17AM  
Jul-01-20 02:33PM  
08:30AM  
07:30AM  
Jun-30-20 05:33PM  
07:41AM  
05:46AM  
05:30AM  
Jun-29-20 05:45PM  
01:50PM  
12:10PM  
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers related products and services. The company offers integrated products and services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid payment programs and management services; and commercial payment products and solutions. It also provides value-added products and services comprising cyber and intelligence products, information and analytics services, consulting services, loyalty and reward programs, processing services, and issuer and acquirer processing services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus brands. The company was founded in 1966 and is headquartered in Purchase, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fraccaro MichaelChief Human Resources OfficerAug 06Option Exercise112.312,969333,4488,233Aug 06 06:34 PM
Fraccaro MichaelChief Human Resources OfficerAug 06Sale330.003,4571,140,8104,776Aug 06 06:34 PM
Fraccaro MichaelChief Human Resources OfficerAug 05Option Exercise95.952,968284,7858,720Aug 06 06:34 PM
Vosburg CraigPresident, North AmericaAug 05Option Exercise90.138,314749,34143,839Aug 06 06:38 PM
Arkell Sandra AControllerAug 05Sale325.001,455472,8753,263Aug 06 06:41 PM
Vosburg CraigPresident, North AmericaAug 05Sale320.008,3142,660,48035,525Aug 06 06:38 PM
Fraccaro MichaelChief Human Resources OfficerAug 05Sale325.003,4561,123,2005,264Aug 06 06:34 PM
SACHIN J. MEHRAChief Financial OfficerJul 31Option Exercise77.7213,9961,087,76924,918Aug 03 04:31 PM
SACHIN J. MEHRAChief Financial OfficerJul 31Sale308.9613,9964,324,19810,922Aug 03 04:31 PM
Haythornthwaite RichardDirectorJul 30Sale307.295,0001,536,45828,088Jul 31 05:14 PM
BANGA AJAYChief Executive OfficerJul 23Option Exercise51.8361,0673,165,103384,371Jul 24 04:52 PM
BANGA AJAYChief Executive OfficerJul 23Sale315.8961,06719,290,278323,304Jul 24 04:52 PM
Mastercard Foundation10% OwnerJul 22Sale311.8768,66121,413,347109,727,813Jul 22 05:05 PM
Mastercard Foundation10% OwnerJul 21Sale310.1068,67021,294,615109,796,474Jul 21 07:14 PM
Mastercard Foundation10% OwnerJul 20Sale308.5468,67021,187,716109,865,144Jul 21 07:14 PM
Mastercard Foundation10% OwnerJul 17Sale300.8568,67020,659,212109,933,814Jul 21 07:14 PM
Mastercard Foundation10% OwnerJul 16Sale300.6568,67020,645,594110,002,484Jul 16 04:52 PM
Mastercard Foundation10% OwnerJul 15Sale304.8368,67020,932,367110,071,154Jul 16 04:52 PM
Mastercard Foundation10% OwnerJul 14Sale292.1768,67020,063,541110,139,824Jul 16 04:52 PM
Mastercard Foundation10% OwnerJul 13Sale296.7568,67020,377,658110,208,494Jul 13 04:52 PM
Mastercard Foundation10% OwnerJul 10Sale293.6068,67020,161,697110,277,164Jul 13 04:52 PM
Mastercard Foundation10% OwnerJul 09Sale295.1268,67020,265,801110,345,834Jul 13 04:52 PM
Mastercard Foundation10% OwnerJul 08Sale299.6868,67020,578,978110,414,504Jul 08 04:32 PM
Mastercard Foundation10% OwnerJul 07Sale306.2068,67021,026,788110,483,174Jul 08 04:32 PM
Mastercard Foundation10% OwnerJul 06Sale305.3268,67020,966,112110,551,844Jul 08 04:32 PM
Mastercard Foundation10% OwnerJul 02Sale303.8668,67020,866,155110,620,514Jul 02 04:38 PM
Mastercard Foundation10% OwnerJun 30Sale292.9068,67020,113,203110,689,184Jul 02 04:38 PM
Mastercard Foundation10% OwnerJun 29Sale289.8768,67019,905,352110,757,854Jun 29 05:49 PM
Mastercard Foundation10% OwnerJun 25Sale293.6768,67020,166,044110,826,524Jun 29 05:49 PM
Mastercard Foundation10% OwnerJun 24Sale299.0868,67020,538,023110,895,194Jun 24 04:35 PM
Mastercard Foundation10% OwnerJun 23Sale307.3168,67021,103,094110,963,864Jun 24 04:35 PM
Cairns AnnVice ChairmanJun 22Option Exercise89.3540,1153,584,279144,971Jun 23 05:20 PM
Mastercard Foundation10% OwnerJun 22Sale301.9968,67020,737,852111,032,534Jun 24 04:35 PM
Cairns AnnVice ChairmanJun 22Sale302.5840,11512,138,078104,856Jun 23 05:20 PM
BANGA AJAYChief Executive OfficerJun 10Option Exercise51.83102,0005,286,660425,304Jun 12 04:35 PM
Madabhushi Venkata RChief Marketing OfficerJun 10Option Exercise93.606,389598,01423,793Jun 12 04:34 PM
BANGA AJAYChief Executive OfficerJun 10Sale315.28102,00032,159,018323,304Jun 12 04:35 PM
Madabhushi Venkata RChief Marketing OfficerJun 10Sale315.157,7362,438,02816,057Jun 12 04:34 PM
Freiberg Steven JDirectorMay 26Sale304.2515,0004,563,7028,384May 27 01:02 PM
Freiberg Steven JDirectorMay 26Sale303.984,2301,285,8175,376May 27 01:02 PM
BANGA AJAYChief Executive OfficerMay 18Option Exercise51.8381,5334,225,855404,837May 19 04:49 PM
Murphy Timothy HGeneral CounselMay 18Option Exercise90.1044,4044,000,80084,004May 19 04:49 PM
BANGA AJAYChief Executive OfficerMay 18Sale287.4481,53323,435,633323,304May 19 04:49 PM
Murphy Timothy HGeneral CounselMay 18Sale286.2852,48915,026,59531,515May 19 04:49 PM
GENACHOWSKI JULIUSDirectorMay 11Sale281.792,009566,1087,346May 12 05:31 PM
Uggla Lance Darrell GordonDirectorMar 11Buy265.001,000265,0005,691Mar 11 05:20 PM
Madabhushi Venkata RChief Marketing OfficerFeb 11Option Exercise173.49954165,50913,093Feb 11 04:53 PM
Madabhushi Venkata RChief Marketing OfficerFeb 11Sale335.00954319,59012,139Feb 11 04:53 PM
Mastercard Foundation10% OwnerFeb 11Sale333.1138,53912,837,680111,101,204Feb 11 05:06 PM
Mastercard Foundation10% OwnerFeb 10Sale328.1138,53612,644,128111,139,743Feb 11 05:06 PM
Mastercard Foundation10% OwnerFeb 07Sale328.5538,53612,661,057111,178,279Feb 07 05:18 PM
Mastercard Foundation10% OwnerFeb 06Sale329.9438,53612,714,545111,216,815Feb 07 05:18 PM
Madabhushi Venkata RChief Marketing OfficerFeb 05Option Exercise146.095,745839,28419,631Feb 06 04:49 PM
Mastercard Foundation10% OwnerFeb 05Sale327.4338,53612,617,804111,255,351Feb 07 05:18 PM
Madabhushi Venkata RChief Marketing OfficerFeb 05Sale335.007,4922,509,82012,139Feb 06 04:49 PM
Mastercard Foundation10% OwnerFeb 04Sale329.7838,53612,708,402111,293,887Feb 04 04:59 PM
Madabhushi Venkata RChief Marketing OfficerFeb 03Option Exercise101.096,698677,11622,331Feb 04 04:31 PM
Madabhushi Venkata RChief Marketing OfficerFeb 03Sale325.008,4452,744,62513,886Feb 04 04:31 PM
Mastercard Foundation10% OwnerFeb 03Sale322.0238,53612,409,424111,332,423Feb 04 04:59 PM
Mastercard Foundation10% OwnerJan 31Sale320.7738,53612,361,343111,370,959Feb 04 04:59 PM
Mastercard Foundation10% OwnerJan 30Sale320.1638,53612,337,643111,409,495Jan 30 05:12 PM
Mastercard Foundation10% OwnerJan 29Sale320.5338,53612,351,933111,448,031Jan 30 05:12 PM
Mastercard Foundation10% OwnerJan 28Sale318.7838,53612,284,429111,486,567Jan 30 05:12 PM
Madabhushi Venkata RChief Marketing OfficerJan 27Option Exercise90.126,698603,63124,077Jan 28 05:21 PM
Caldart GilbertoPresident, InternationalJan 27Option Exercise90.1320,9641,889,48520,964Jan 28 05:24 PM
Mastercard Foundation10% OwnerJan 27Sale317.4138,53612,231,692111,525,103Jan 27 04:42 PM
Madabhushi Venkata RChief Marketing OfficerJan 27Sale315.008,4442,659,86015,633Jan 28 05:21 PM
Caldart GilbertoPresident, InternationalJan 27Sale317.2020,9646,649,8530Jan 28 05:24 PM
Mastercard Foundation10% OwnerJan 24Sale325.7838,53612,554,065111,563,639Jan 27 04:42 PM
Mastercard Foundation10% OwnerJan 23Sale323.5738,53612,469,059111,602,175Jan 27 04:42 PM
Mastercard Foundation10% OwnerJan 22Sale325.4538,53612,541,726111,640,711Jan 22 05:00 PM
Bhalla AjayPresident Cyber & IntelligenceJan 21Option Exercise24.043,48083,6459,837Jan 22 04:35 PM
Miebach MichaelChief Product OfficerJan 21Option Exercise90.104,205378,87116,983Jan 22 04:37 PM
Miebach MichaelChief Product OfficerJan 21Sale325.004,2051,366,62512,778Jan 22 04:37 PM
Bhalla AjayPresident Cyber & IntelligenceJan 21Sale325.003,4801,131,0006,357Jan 22 04:35 PM
Mastercard Foundation10% OwnerJan 21Sale323.8438,53612,479,406111,679,247Jan 22 05:00 PM
Mastercard Foundation10% OwnerJan 17Sale321.6038,53612,393,305111,717,783Jan 22 05:00 PM
Mastercard Foundation10% OwnerJan 16Sale317.0338,53612,217,072111,756,319Jan 16 04:35 PM
Mastercard Foundation10% OwnerJan 15Sale313.1938,53612,068,920111,794,855Jan 16 04:35 PM
Mastercard Foundation10% OwnerJan 14Sale312.7538,53612,051,988111,833,391Jan 16 04:35 PM
Miebach MichaelChief Product OfficerJan 13Option Exercise90.104,205378,87116,983Jan 13 04:19 PM
Miebach MichaelChief Product OfficerJan 13Sale315.004,2051,324,57512,778Jan 13 04:19 PM
Bhalla AjayPresident Cyber & IntelligenceJan 09Option Exercise24.034,00096,12010,357Jan 09 04:44 PM
Bhalla AjayPresident Cyber & IntelligenceJan 09Sale310.004,0001,240,0006,357Jan 09 04:44 PM
Miebach MichaelChief Product OfficerJan 08Option Exercise90.104,205378,87116,983Jan 09 04:48 PM
Miebach MichaelChief Product OfficerJan 08Sale305.004,2051,282,52512,778Jan 09 04:48 PM
McLaughlin Edward GrundePresident, Operations & TechJan 02Option Exercise84.1720,8181,752,22654,033Jan 06 12:13 PM
McLaughlin Edward GrundePresident, Operations & TechJan 02Sale302.1628,5268,619,38625,507Jan 06 12:13 PM
Bhalla AjayPresident Cyber & IntelligenceDec 27Option Exercise24.036,000144,18012,357Dec 27 12:15 PM
Bhalla AjayPresident Cyber & IntelligenceDec 27Sale300.006,0001,800,0006,357Dec 27 12:15 PM
Miebach MichaelChief Product OfficerDec 13Option Exercise90.104,205378,87116,983Dec 16 02:02 PM
Miebach MichaelChief Product OfficerDec 13Sale295.104,2051,240,89212,778Dec 16 02:02 PM
Mastercard Foundation10% OwnerNov 11Sale275.677,5472,080,502111,871,927Nov 12 04:53 PM
Mastercard Foundation10% OwnerNov 08Sale273.527,5422,062,917111,879,474Nov 12 04:53 PM
Mastercard Foundation10% OwnerNov 07Sale272.777,5422,057,205111,887,016Nov 07 05:12 PM
Mastercard Foundation10% OwnerNov 06Sale270.007,5422,036,322111,894,558Nov 07 05:12 PM
Mastercard Foundation10% OwnerNov 05Sale270.677,5422,041,381111,902,100Nov 07 05:12 PM
Mastercard Foundation10% OwnerNov 04Sale278.377,5422,099,429111,909,642Nov 04 05:06 PM
Haythornthwaite RichardDirectorNov 01Sale280.005,0001,400,00032,119Nov 04 05:51 PM
Mastercard Foundation10% OwnerNov 01Sale278.137,5422,097,690111,917,184Nov 04 05:06 PM
UNH UnitedHealth Group Incorporated weekly Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E17.83 EPS (ttm)17.78 Insider Own0.30% Shs Outstand949.00M Perf Week4.71%
Market Cap303.10B Forward P/E17.10 EPS next Y18.54 Insider Trans-10.93% Shs Float942.14M Perf Month8.89%
Income17.10B PEG1.40 EPS next Q3.11 Inst Own89.50% Short Float0.54% Perf Quarter10.46%
Sales247.81B P/S1.22 EPS this Y17.50% Inst Trans0.11% Short Ratio1.38 Perf Half Y9.62%
Book/sh60.04 P/B5.28 EPS next Y11.85% ROA7.90% Target Price331.96 Perf Year28.03%
Cash/sh22.56 P/C14.05 EPS next 5Y12.72% ROE24.90% 52W Range187.72 - 316.24 Perf YTD7.84%
Dividend5.00 P/FCF24.33 EPS past 5Y20.20% ROI16.20% 52W High0.25% Beta0.72
Dividend %1.58% Quick Ratio- Sales past 5Y13.20% Gross Margin- 52W Low68.88% ATR7.11
Employees325000 Current Ratio- Sales Q/Q6.80% Oper. Margin7.90% RSI (14)63.33 Volatility2.23% 2.40%
OptionableYes Debt/Eq0.91 EPS Q/Q-1.10% Profit Margin5.60% Rel Volume0.71 Prev Close314.06
ShortableYes LT Debt/Eq0.63 EarningsJul 15 BMO Payout28.50% Avg Volume3.66M Price317.03
Recom1.80 SMA204.22% SMA505.67% SMA20012.58% Volume2,598,529 Change0.95%
Jul-01-20Resumed SVB Leerink Outperform $360
Jun-05-20Initiated Goldman Buy $384
Mar-20-20Upgrade Deutsche Bank Hold → Buy $308
Oct-18-19Initiated Mizuho Buy $270
Oct-10-19Downgrade Jefferies Buy → Hold $300 → $235
Sep-30-19Downgrade BMO Capital Markets Outperform → Market Perform $292 → $249
Sep-12-19Initiated Deutsche Bank Hold
May-10-19Upgrade Citigroup Neutral → Buy $247 → $280
Apr-23-19Initiated UBS Neutral $238
Apr-17-19Reiterated BofA/Merrill Buy $320 → $290
Jan-14-19Initiated Stephens Overweight $287
Sep-10-18Downgrade Citigroup Buy → Neutral
Jun-11-18Initiated SunTrust Buy $300
Mar-08-18Initiated Barclays Overweight $265
Jan-17-18Reiterated Citigroup Buy $235 → $268
Jan-12-18Reiterated Evercore ISI Outperform $235 → $255
Jan-03-18Initiated Goldman Buy $269
Jul-19-17Reiterated Mizuho Buy $200 → $235
Jun-07-17Initiated Morgan Stanley Overweight
Apr-18-17Reiterated Mizuho Buy $178 → $200
Aug-07-20 04:25PM  
12:24PM  
Aug-06-20 04:25PM  
02:24PM  
07:27AM  
Aug-05-20 04:25PM  
04:24PM  
09:57AM  
06:50AM  
06:44AM  
Aug-04-20 04:25PM  
11:13AM  
11:00AM  
Aug-03-20 04:25PM  
Jul-31-20 04:25PM  
Jul-30-20 07:46PM  
04:25PM  
02:00PM  
06:30AM  
06:00AM  
Jul-29-20 03:34PM  
02:32PM  
11:44AM  
11:41AM  
10:09AM  
Jul-28-20 06:41AM  
Jul-27-20 06:33PM  
03:18PM  
11:03AM  
Jul-24-20 11:11AM  
Jul-23-20 12:17PM  
10:25AM  
Jul-22-20 10:36AM  
10:06AM  
07:51AM  
07:44AM  
Jul-20-20 11:00AM  
Jul-17-20 08:14PM  
05:44PM  
04:23PM  
11:35AM  
09:51AM  
Jul-16-20 02:58PM  
02:14PM  
01:16PM  
11:30AM  
11:15AM  
03:00AM  
Jul-15-20 05:53PM  
04:45PM  
04:45PM  
04:07PM  
01:28PM  
12:45PM  
12:45PM  
12:40PM  
12:20PM  
11:34AM  
10:34AM  
10:27AM  
10:18AM  
10:00AM  
09:59AM  
09:59AM  
09:34AM  
09:23AM  
09:06AM  
08:53AM  
07:36AM  
07:31AM  
07:30AM  
06:55AM  
06:14AM  
05:55AM  
Jul-14-20 11:11PM  
05:00PM  
03:01PM  
02:42PM  
02:11PM  
10:57AM  
08:35AM  
06:30AM  
Jul-13-20 07:00PM  
03:50PM  
02:49PM  
01:49PM  
12:48PM  
12:37PM  
11:46AM  
10:46AM  
09:45AM  
08:00AM  
06:43AM  
Jul-10-20 05:50PM  
Jul-09-20 10:00AM  
10:00AM  
10:00AM  
09:58AM  
09:00AM  
09:00AM  
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURKE RICHARD TDirectorJul 22Sale303.5010,0003,035,0171,376,500Jul 23 04:27 PM
REX JOHN FEVP Chief Financial OfficerJul 17Option Exercise56.0480,0004,483,200157,847Jul 20 09:49 PM
REX JOHN FEVP Chief Financial OfficerJul 17Sale308.4322,1746,839,10588,934Jul 20 09:49 PM
HEMSLEY STEPHEN JDirectorJul 17Sale307.74170,00052,315,800739,059Jul 20 09:48 PM
HEMSLEY STEPHEN JDirectorJul 16Sale307.0459,01218,118,773909,059Jul 20 09:48 PM
HEMSLEY STEPHEN JDirectorMay 11Sale289.1145,63713,194,022967,485May 12 04:32 PM
BURKE RICHARD TDirectorMar 20Sale228.3910,0002,283,9211,386,500Mar 23 05:23 PM
BURKE RICHARD TDirectorMar 19Sale224.405,0001,122,0001,396,500Mar 20 05:00 PM
BURKE RICHARD TDirectorMar 18Sale212.005,0001,060,0001,401,500Mar 20 05:00 PM
BURKE RICHARD TDirectorMar 17Sale240.1010,0002,401,0371,406,500Mar 18 04:26 PM
BURKE RICHARD TDirectorMar 16Sale237.005,0001,185,0001,416,500Mar 18 04:26 PM
BURKE RICHARD TDirectorFeb 19Sale306.0410,0003,060,3851,421,500Feb 21 04:11 PM
WICHMANN DAVID SChief Executive OfficerFeb 07Option Exercise33.0076,0242,508,792976,537Feb 11 04:58 PM
BURKE RICHARD TDirectorJan 16Sale299.4515,0004,491,7501,431,500Jan 21 06:01 PM
HEMSLEY STEPHEN JExecutive Chair of the BoardDec 19Option Exercise33.00114,0363,763,1881,533,391Dec 19 06:12 PM
WILSON D ELLENExecutive Vice PresidentNov 18Sale273.867,4002,026,54950,007Nov 19 04:48 PM
ROOS THOMAS EChief Accounting OfficerNov 07Sale255.041,177300,17721,687Nov 08 04:40 PM
BURKE RICHARD TDirectorOct 16Sale236.5625,0005,914,015163,331Oct 18 04:09 PM
BURKE RICHARD TDirectorSep 20Sale234.202,500585,5001,446,500Sep 23 04:17 PM
BURKE RICHARD TDirectorSep 19Sale233.402,500583,5001,449,000Sep 23 04:17 PM
BURKE RICHARD TDirectorSep 18Sale232.602,500581,5001,451,500Sep 19 04:50 PM
BURKE RICHARD TDirectorSep 17Sale232.762,500581,8971,454,000Sep 19 04:50 PM
FLYNN TIMOTHY PATRICKDirectorAug 28Buy227.552,000455,0945,524Aug 29 04:56 PM
BURKE RICHARD TDirectorAug 23Sale231.502,000463,0001,456,500Aug 26 05:08 PM
HON Honeywell International Inc. weekly Stock Chart
HON [NYSE]
Honeywell International Inc.
IndexS&P 500 P/E20.04 EPS (ttm)7.74 Insider Own0.10% Shs Outstand702.30M Perf Week3.84%
Market Cap108.70B Forward P/E19.81 EPS next Y7.83 Insider Trans-0.29% Shs Float700.65M Perf Month9.72%
Income5.57B PEG8.22 EPS next Q1.50 Inst Own79.00% Short Float0.63% Perf Quarter13.29%
Sales34.52B P/S3.15 EPS this Y-4.40% Inst Trans1.43% Short Ratio1.24 Perf Half Y-11.51%
Book/sh25.84 P/B6.00 EPS next Y13.53% ROA9.80% Target Price157.85 Perf Year-7.13%
Cash/sh21.59 P/C7.19 EPS next 5Y2.44% ROE32.30% 52W Range101.08 - 184.06 Perf YTD-12.37%
Dividend3.60 P/FCF35.21 EPS past 5Y8.50% ROI17.20% 52W High-15.73% Beta1.03
Dividend %2.32% Quick Ratio1.40 Sales past 5Y-1.90% Gross Margin32.90% 52W Low53.45% ATR3.32
Employees113000 Current Ratio1.60 Sales Q/Q-19.10% Oper. Margin20.00% RSI (14)57.22 Volatility1.78% 2.07%
OptionableYes Debt/Eq1.22 EPS Q/Q-27.40% Profit Margin16.90% Rel Volume0.71 Prev Close152.58
ShortableYes LT Debt/Eq0.97 EarningsJul 24 BMO Payout42.80% Avg Volume3.57M Price155.11
Recom1.90 SMA202.89% SMA504.25% SMA200-1.65% Volume2,518,977 Change1.66%
May-21-20Upgrade HSBC Securities Hold → Buy $158
May-04-20Downgrade Deutsche Bank Buy → Hold $165 → $149
Mar-31-20Downgrade Atlantic Equities Overweight → Neutral $158
Mar-23-20Upgrade Daiwa Securities Neutral → Outperform $129
Mar-23-20Downgrade Morgan Stanley Overweight → Equal-Weight $121
Dec-12-19Initiated UBS Neutral $192
Jan-08-19Downgrade Oppenheimer Outperform → Perform
Jan-04-19Upgrade RBC Capital Mkts Sector Perform → Outperform
Jan-03-19Upgrade Credit Suisse Neutral → Outperform
Oct-12-18Initiated Gordon Haskett Buy
Oct-12-18Initiated Credit Suisse Neutral
Oct-02-18Downgrade HSBC Securities Buy → Hold $162
Aug-21-18Initiated Morgan Stanley Overweight $175
Feb-15-18Initiated Barclays Overweight $170
Jan-03-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-14-17Reiterated Stifel Buy $171 → $169
Dec-14-17Reiterated Jefferies Buy $162 → $180
Oct-23-17Reiterated RBC Capital Mkts Outperform $148 → $156
Oct-12-17Reiterated Argus Buy $152 → $160
Oct-09-17Reiterated Citigroup Buy $155 → $170
Aug-07-20 11:41AM  
Aug-06-20 04:25PM  
04:25PM  
Aug-05-20 04:25PM  
01:40PM  
01:00PM  
09:00AM  
07:50AM  
Aug-04-20 04:25PM  
01:03PM  
Aug-03-20 04:25PM  
02:15PM  
Jul-31-20 05:21PM  
04:25PM  
01:10PM  
12:01PM  
11:00AM  
09:51AM  
Jul-30-20 04:25PM  
12:25PM  
09:11AM  
Jul-29-20 04:25PM  
03:50PM  
01:14PM  
12:24PM  
08:30AM  
Jul-28-20 04:45PM  
01:00PM  
12:09PM  
08:45AM  
Jul-27-20 05:00PM  
01:50PM  
11:35AM  
09:36AM  
Jul-25-20 04:00PM  
02:40PM  
08:18AM  
Jul-24-20 09:01PM  
07:10PM  
06:17PM  
04:30PM  
04:03PM  
04:00PM  
02:36PM  
02:25PM  
11:58AM  
11:35AM  
11:16AM  
10:00AM  
08:24AM  
08:23AM  
07:47AM  
07:20AM  
06:41AM  
06:40AM  
06:30AM  
04:19AM  
Jul-23-20 04:32PM  
02:49PM  
01:00PM  
11:39AM  
Jul-22-20 05:52PM  
03:30PM  
02:29PM  
09:56AM  
08:27AM  
Jul-21-20 03:33PM  
01:56PM  
12:06PM  
06:17AM  
Jul-20-20 01:12PM  
11:55AM  
10:49AM  
08:58AM  
08:49AM  
06:48AM  
Jul-17-20 01:33PM  
08:12AM  
Jul-16-20 09:00AM  
Jul-15-20 09:12PM  
09:33AM  
Jul-14-20 09:00AM  
Jul-13-20 07:45AM  
Jul-11-20 08:44AM  
Jul-10-20 05:00PM  
Jul-09-20 03:55PM  
05:00AM  
Jul-08-20 08:32AM  
08:02AM  
Jul-07-20 06:18AM  
Jul-06-20 01:00PM  
Jul-02-20 03:13PM  
Jul-01-20 06:20AM  
Jun-30-20 01:29PM  
07:51AM  
Jun-29-20 09:18PM  
11:02AM  
Jun-26-20 10:50PM  
11:30AM  
08:30AM  
Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. The Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; thermal systems; and connected solutions and data services for the aftermarket, as well as wireless connectivity, and management and technical services. The company's Honeywell Building Technologies segment offers advanced software applications for building control and optimization; sensors, switches, control systems and instruments for energy management; access control; video surveillance; fire products; remote patient monitoring systems; e-cooling heat transfer agents; and installation, maintenance, and upgrades of systems. Its Performance Materials and Technologies segment offers automation control, instrumentation, and advanced software and related services; catalysts and adsorbents, equipment, and consulting; and materials used to manufacture end products, such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, as well as Honeywell forge connected solutions. The company's Safety and Productivity Solutions segment provides personal protection equipment, apparel, gear, and footwear; gas detection technology; and cloud-based notification and emergency messaging; and mobile devices and software; supply chain and warehouse automation equipment, and software and solutions; custom-engineered sensors, switches, and controls; and software-based data and asset management productivity solutions. Honeywell International Inc. was incorporated in 1985 and is headquartered in Charlotte, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewis Gregory PSrVP & Chief Financial OfficerAug 04Option Exercise54.323,675199,62622,276Aug 05 04:10 PM
Madden Anne TSrVP and General CounselJul 29Option Exercise57.0021,0071,197,39938,164Jul 30 08:22 PM
BURKE KEVINDirectorMay 15Option Exercise57.581,31375,60319,287May 15 05:20 PM
DAVIS D SCOTTDirectorApr 24Option Exercise134.3042957,61522,804Apr 28 05:04 PM
Washington Robin LDirectorApr 24Option Exercise134.3042957,6155,995Apr 28 05:02 PM
Paz GeorgeDirectorApr 24Option Exercise134.3042957,61515,610Apr 28 05:03 PM
Lieblein GraceDirectorApr 24Option Exercise134.3042957,6156,016Apr 28 05:01 PM
Deily Linnet FDirectorApr 24Option Exercise134.3042957,6156,344Apr 28 05:01 PM
HOLLICK CLIVE RDirectorApr 24Option Exercise134.3042957,61517,493Apr 28 04:59 PM
Gregg Judd A.DirectorApr 24Option Exercise134.3042957,61512,122Apr 28 04:58 PM
Pardo Jaime ChicoDirectorApr 24Option Exercise134.3042957,615932Apr 28 04:56 PM
BURKE KEVINDirectorApr 24Option Exercise134.3042957,61517,974Apr 28 04:55 PM
AYER WILLIAM SDirectorApr 24Option Exercise134.3042957,6154,983Apr 28 04:54 PM
Gregg Judd A.DirectorFeb 21Option Exercise57.585,250302,29514,693Feb 25 04:04 PM
James Mark R.SVP-HR Security & CommsFeb 20Option Exercise61.72241,59414,909,974342,607Feb 24 05:04 PM
Paz GeorgeDirectorFeb 18Option Exercise45.815,250240,50316,524Feb 20 04:09 PM
Deily Linnet FDirectorFeb 18Sale179.012,003358,5576,045Feb 20 04:06 PM
BURKE KEVINDirectorFeb 14Option Exercise57.581,31375,60318,261Feb 19 04:03 PM
HOLLICK CLIVE RDirectorFeb 05Option Exercise52.6913,572715,07519,343Feb 07 04:32 PM
BURKE KEVINDirectorNov 15Option Exercise45.811,31160,05717,617Nov 18 04:09 PM
Deily Linnet FDirectorOct 25Option Exercise70.903,152223,47710,811Oct 29 07:40 PM
Gautam RajeevPresident & CEO, PMTAug 20Sale163.8810,9841,800,05828,920Aug 21 04:05 PM
Adamczyk DariusChairman and CEOAug 16Sale165.087,1491,180,15775,521Aug 16 05:36 PM
BURKE KEVINDirectorAug 15Option Exercise45.812,624120,20517,706Aug 16 05:31 PM
Pardo Jaime ChicoDirectorAug 13Sale168.796,6071,115,196496Aug 14 04:05 PM
Pardo Jaime ChicoDirectorAug 12Sale165.927,0001,161,4407,103Aug 14 04:05 PM
MDT Medtronic plc weekly Stock Chart
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E28.61 EPS (ttm)3.50 Insider Own0.10% Shs Outstand1.34B Perf Week3.70%
Market Cap134.18B Forward P/E17.90 EPS next Y5.59 Insider Trans0.51% Shs Float1.34B Perf Month11.01%
Income4.73B PEG2.98 EPS next Q0.15 Inst Own84.90% Short Float0.58% Perf Quarter1.03%
Sales28.91B P/S4.64 EPS this Y2.30% Inst Trans0.10% Short Ratio1.37 Perf Half Y-15.89%
Book/sh37.84 P/B2.64 EPS next Y54.11% ROA5.20% Target Price110.17 Perf Year-2.18%
Cash/sh8.16 P/C12.26 EPS next 5Y9.62% ROE9.40% 52W Range72.13 - 122.15 Perf YTD-11.81%
Dividend2.32 P/FCF42.91 EPS past 5Y7.70% ROI6.70% 52W High-18.09% Beta0.68
Dividend %2.32% Quick Ratio1.70 Sales past 5Y7.40% Gross Margin67.90% 52W Low38.71% ATR2.15
Employees90000 Current Ratio2.10 Sales Q/Q-26.40% Oper. Margin15.10% RSI (14)60.70 Volatility1.92% 2.12%
OptionableYes Debt/Eq0.49 EPS Q/Q-47.40% Profit Margin16.60% Rel Volume0.79 Prev Close96.73
ShortableYes LT Debt/Eq0.43 EarningsAug 25 BMO Payout60.50% Avg Volume5.68M Price100.05
Recom2.00 SMA203.98% SMA505.22% SMA200-2.51% Volume4,471,878 Change3.43%
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
Aug-27-18Reiterated Argus Buy $95 → $108
Aug-22-18Reiterated Stifel Hold $87 → $96
Aug-13-18Upgrade Needham Buy → Strong Buy $103 → $119
Jun-27-18Initiated Bernstein Mkt Perform $88
Jun-06-18Resumed William Blair Mkt Perform
Jun-06-18Reiterated Needham Buy $97 → $103
Aug-05-20 07:00AM  
Aug-03-20 12:22PM  
07:00AM  
Aug-02-20 07:33AM  
Jul-27-20 05:50PM  
Jul-22-20 09:00AM  
Jul-17-20 07:18PM  
03:59PM  
Jul-15-20 11:01AM  
10:34AM  
07:30AM  
06:21AM  
02:30AM  
02:30AM  
Jul-14-20 09:29AM  
Jul-13-20 07:00PM  
01:32PM  
Jul-11-20 07:13AM  
Jul-09-20 10:05AM  
09:00AM  
Jul-08-20 03:52PM  
01:17PM  
12:29PM  
11:30AM  
10:27AM  
Jul-07-20 09:15AM  
09:00AM  
Jul-06-20 10:00AM  
Jul-05-20 08:11AM  
Jul-02-20 04:47PM  
Jul-01-20 05:50PM  
Jun-29-20 07:47AM  
Jun-28-20 11:03PM  
Jun-26-20 09:14AM  
Jun-25-20 05:50PM  
11:05AM  
11:00AM  
10:14AM  
08:00AM  
Jun-24-20 06:00AM  
Jun-23-20 10:52AM  
Jun-22-20 04:43PM  
09:00AM  
Jun-20-20 11:30AM  
Jun-19-20 10:14AM  
Jun-18-20 03:15PM  
03:07PM  
08:44AM  
08:41AM  
08:30AM  
Jun-17-20 09:19AM  
Jun-16-20 12:00PM  
Jun-15-20 09:00AM  
06:54AM  
02:28AM  
Jun-14-20 06:25AM  
04:04AM  
Jun-13-20 11:00AM  
Jun-12-20 05:30PM  
05:00PM  
11:46AM  
Jun-11-20 09:00AM  
Jun-09-20 03:00PM  
11:30AM  
10:23AM  
Jun-08-20 12:00PM  
Jun-05-20 09:00AM  
Jun-03-20 11:00AM  
Jun-02-20 01:00PM  
11:21AM  
11:05AM  
May-29-20 11:00AM  
May-26-20 03:21PM  
12:59PM  
09:02AM  
May-24-20 07:05AM  
May-22-20 11:00AM  
09:25AM  
09:00AM  
06:07AM  
May-21-20 05:01PM  
04:16PM  
02:51PM  
02:00PM  
12:18PM  
08:05AM  
07:47AM  
06:45AM  
May-20-20 07:43AM  
May-19-20 10:00AM  
May-18-20 04:21PM  
03:19PM  
12:00PM  
11:43AM  
May-16-20 09:15AM  
06:00AM  
May-15-20 01:30PM  
11:21AM  
08:07AM  
May-14-20 12:30PM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Surface Carol ASVP, Chief HR OfficerMay 29Sale97.722,000195,44047,443Jun 02 05:39 PM
OLEARY DENISE MDirectorApr 03Option Exercise44.131,81380,00866,544Apr 07 06:17 PM
ISHRAK OMARChairman & CEOFeb 20Buy113.688,771997,087605,190Feb 24 08:56 AM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Option Exercise54.5542,7702,333,054109,571Dec 26 05:36 PM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Sale113.5850,8565,776,10171,013Dec 26 05:36 PM
ANDERSON RICHARD HDirectorDec 06Buy113.295,000566,45095,231Dec 09 05:36 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Option Exercise61.2652,1663,195,798104,234Dec 03 04:25 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Sale110.6252,1665,770,82952,068Dec 03 04:25 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Option Exercise38.8136,8741,431,080225,136Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Sale111.2536,8744,102,092188,262Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Option Exercise40.412,10284,932189,464Nov 15 05:49 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Sale109.772,102230,731188,262Nov 15 05:49 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Option Exercise36.3452,1651,895,47895,158Nov 04 06:28 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Option Exercise38.9038,9761,516,012226,036Nov 04 06:26 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Sale109.3352,1655,702,99552,068Nov 04 06:28 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Sale109.5038,9764,267,872188,262Nov 04 06:26 PM
Surface Carol ASVP, Chief HR OfficerOct 11Option Exercise80.8584,2076,808,395121,920Oct 15 04:37 PM
WHITE ROBERT JOHNEVP & President MITGOct 01Option Exercise28.1752,1651,469,549104,082Oct 02 04:54 PM
Kuntz RichardSVP & Chief Medical & ScienceSep 27Sale107.5121,4252,303,49378,816Sep 30 05:52 PM
Lenehan James TDirectorSep 25Option Exercise44.131,81380,00855,464Sep 26 06:20 PM
HAKAMI HOOMANEVP & Group President DiabetesSep 10Option Exercise85.7072,8776,245,60458,015Sep 12 05:55 PM
HAKAMI HOOMANEVP & Group President DiabetesSep 10Sale107.3182,8778,893,71230,761Sep 12 05:55 PM
ABT Abbott Laboratories weekly Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E58.55 EPS (ttm)1.73 Insider Own0.70% Shs Outstand1.77B Perf Week0.59%
Market Cap180.82B Forward P/E26.00 EPS next Y3.89 Insider Trans-2.13% Shs Float1.76B Perf Month8.07%
Income3.08B PEG5.08 EPS next Q0.89 Inst Own76.30% Short Float0.58% Perf Quarter8.04%
Sales31.44B P/S5.75 EPS this Y45.20% Inst Trans0.16% Short Ratio1.70 Perf Half Y15.20%
Book/sh17.25 P/B5.87 EPS next Y20.01% ROA4.60% Target Price105.76 Perf Year18.31%
Cash/sh2.82 P/C35.90 EPS next 5Y11.53% ROE10.10% 52W Range61.61 - 102.89 Perf YTD16.54%
Dividend1.44 P/FCF84.22 EPS past 5Y12.40% ROI8.20% 52W High-1.62% Beta0.98
Dividend %1.42% Quick Ratio1.10 Sales past 5Y9.50% Gross Margin57.70% 52W Low64.31% ATR2.18
Employees107000 Current Ratio1.60 Sales Q/Q-8.20% Oper. Margin12.80% RSI (14)60.44 Volatility1.77% 2.13%
OptionableYes Debt/Eq0.64 EPS Q/Q-46.70% Profit Margin9.90% Rel Volume0.53 Prev Close101.75
ShortableYes LT Debt/Eq0.59 EarningsJul 16 BMO Payout77.40% Avg Volume5.97M Price101.23
Recom2.00 SMA202.27% SMA507.51% SMA20015.37% Volume3,141,766 Change-0.51%
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Aug-07-20 02:25PM  
Aug-06-20 04:21PM  
Aug-05-20 10:20AM  
Aug-04-20 12:44PM  
09:00AM  
Aug-01-20 06:44AM  
Jul-29-20 08:01AM  
Jul-28-20 05:35PM  
09:48AM  
08:11AM  
Jul-27-20 07:00AM  
Jul-26-20 07:32AM  
Jul-24-20 07:06PM  
06:11PM  
10:15AM  
08:00AM  
07:23AM  
Jul-23-20 09:00AM  
Jul-22-20 09:58AM  
07:51AM  
05:30AM  
Jul-21-20 07:29PM  
02:16PM  
09:07AM  
Jul-20-20 08:01AM  
Jul-19-20 07:00AM  
Jul-18-20 08:02AM  
Jul-17-20 07:18PM  
10:24AM  
09:36AM  
08:45AM  
06:25AM  
12:04AM  
Jul-16-20 06:24PM  
04:23PM  
01:11PM  
11:43AM  
10:35AM  
10:23AM  
10:21AM  
09:49AM  
08:58AM  
08:55AM  
08:14AM  
08:00AM  
07:48AM  
07:39AM  
07:30AM  
04:10AM  
Jul-14-20 10:10AM  
Jul-13-20 11:58PM  
04:51PM  
04:15PM  
10:02AM  
09:54AM  
Jul-12-20 04:53PM  
06:35AM  
Jul-10-20 12:49PM  
Jul-09-20 04:07PM  
12:30PM  
11:30AM  
09:32AM  
Jul-08-20 08:48AM  
Jul-07-20 03:42PM  
09:40AM  
Jul-06-20 04:03PM  
07:30AM  
06:31AM  
Jul-04-20 07:32AM  
Jul-02-20 10:31PM  
05:45PM  
05:17PM  
Jun-30-20 05:56PM  
02:31PM  
11:52AM  
Jun-29-20 09:13AM  
09:00AM  
07:47AM  
Jun-26-20 05:45PM  
09:00AM  
Jun-25-20 11:06AM  
10:00AM  
Jun-24-20 05:50PM  
03:49PM  
12:23PM  
Jun-23-20 05:32PM  
09:00AM  
07:19AM  
Jun-22-20 09:15AM  
Jun-18-20 05:45PM  
Jun-17-20 06:18PM  
07:11AM  
Jun-16-20 12:34PM  
09:00AM  
09:00AM  
07:00AM  
12:00AM  
Jun-15-20 05:18PM  
11:59AM  
10:49AM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NOVAKOVIC PHEBE NDirectorJul 23Option Exercise25.053,73993,67732,046Jul 27 05:06 PM
NOVAKOVIC PHEBE NDirectorJul 23Sale100.7893394,02631,113Jul 27 05:06 PM
AUSTIN ROXANNE SDirectorJul 22Sale99.806,844683,03840,043Jul 23 05:07 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Option Exercise0.0023,008096,899Jul 23 05:04 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Sale98.0023,0082,254,78473,891Jul 23 05:04 PM
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM
LANE ANDREW HExecutive Vice PresidentMay 05Option Exercise43.8280,0003,505,314145,822May 07 05:02 PM
LANE ANDREW HExecutive Vice PresidentMay 05Sale92.0080,0007,360,10465,822May 07 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 28Sale93.183,724347,01248,767Apr 30 06:34 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Option Exercise22.3950,1001,121,834366,900Apr 23 09:34 PM
Ginascol John FExecutive Vice PresidentApr 21Option Exercise38.4063,2002,426,880129,645Apr 23 09:41 PM
Funck Robert EExecutive Vice President & CFOApr 21Option Exercise36.4236,7001,336,638206,072Apr 23 09:27 PM
Contreras JaimeSenior Vice PresidentApr 21Option Exercise57.12108,4126,192,995145,431Apr 23 09:26 PM
Scoggins Christopher JSenior Vice PresidentApr 21Sale96.1041439,78539,706Apr 23 09:28 PM
Ginascol John FExecutive Vice PresidentApr 21Sale96.0063,2006,067,05166,445Apr 23 09:41 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Sale95.8750,1004,803,326316,800Apr 23 09:34 PM
Boudreau Philip PVice PresidentMar 13Sale82.0010,600869,20022,463Mar 16 06:47 PM
Watkin JaredSenior Vice PresidentMar 06Sale82.008,248676,33668,696Mar 10 05:06 PM
BIRD ROGERSenior Vice PresidentMar 02Sale77.8966651,87562,920Mar 03 05:23 PM
DALE MICHAEL DSenior Vice PresidentMar 02Sale77.8978761,29934,763Mar 03 05:21 PM
Ginascol John FExecutive Vice PresidentMar 02Sale77.636,606512,80566,445Mar 03 05:20 PM
Contreras JaimeSenior Vice PresidentMar 02Sale77.892,001155,85837,019Mar 03 05:19 PM
Watkin JaredSenior Vice PresidentMar 02Sale77.891,761137,16476,944Mar 03 05:19 PM
ALLEN HUBERT LExecutive Vice PresidentMar 02Sale77.891,20894,091151,896Mar 03 05:16 PM
Scoggins Christopher JSenior Vice PresidentMar 02Sale77.891,24096,58441,168Mar 03 05:15 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 02Sale77.8999977,812103,493Mar 03 05:16 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 02Sale77.891,781138,72245,460Mar 03 05:13 PM
Wainer Andrea FExecutive Vice PresidentMar 02Sale77.891,429111,30549,498Mar 03 05:10 PM
Funck Robert EExecutive Vice President & CFOMar 02Sale77.891,356105,619169,372Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentMar 02Sale77.891,420110,60453,859Mar 03 05:27 PM
Moreland Mary KExecutive Vice PresidentFeb 25Sale84.9340033,97266,131Feb 25 05:29 PM
Moreland Mary KExecutive Vice PresidentFeb 19Sale88.971,01990,66052,985Feb 19 05:53 PM
DALE MICHAEL DSenior Vice PresidentFeb 19Sale88.9739635,23223,947Feb 19 05:53 PM
Wainer Andrea FExecutive Vice PresidentFeb 07Sale88.611,12099,24540,140Feb 11 06:10 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Option Exercise45.33509,85023,110,674624,231Jan 30 05:23 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Sale89.73509,85045,747,209114,381Jan 30 05:23 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Option Exercise38.4037,5001,440,00088,032Jan 29 05:06 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Sale89.5837,5003,359,41150,534Jan 29 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Option Exercise38.4016,000614,40068,562Oct 25 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Sale80.5421,0001,691,31547,562Oct 25 05:02 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Option Exercise47.0047,2262,219,62297,755Sep 04 05:20 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Sale85.1447,2264,020,68550,532Sep 04 05:20 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Option Exercise50.7223,0081,166,966104,228Aug 13 07:12 PM
Funck Robert ESenior Vice PresidentAug 09Option Exercise34.9440,0001,397,600178,991Aug 13 07:11 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Sale86.3923,0081,987,70581,220Aug 13 07:12 PM
LOW Lowe's Companies, Inc. weekly Stock Chart
LOW [NYSE]
Lowe's Companies, Inc.
IndexS&P 500 P/E25.78 EPS (ttm)5.93 Insider Own0.17% Shs Outstand755.00M Perf Week2.60%
Market Cap115.57B Forward P/E20.56 EPS next Y7.43 Insider Trans0.76% Shs Float754.48M Perf Month12.66%
Income4.56B PEG1.32 EPS next Q2.63 Inst Own77.60% Short Float1.01% Perf Quarter33.75%
Sales74.08B P/S1.56 EPS this Y92.90% Inst Trans0.34% Short Ratio1.55 Perf Half Y25.77%